SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Patel Ian Kiran
(Last) (First) (Middle)
41 ONEIDA CT.
(Street)
DENVER CO 80230
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CEA Industries Inc. [ CEAD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO, Treasurer & Secretary
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock(1) $2.2 03/11/2022 03/11/2022 A 2,000 03/11/2022 03/11/2032 Common Stock 2,000 (1) 2,000 D
Option to purchase common stock(2) $2.2 03/11/2022 03/11/2022 A 3,000 03/11/2023 03/11/2032 Common Stock 3,000 (2) 3,000 D
Option to purchase common stock(3) $2.2 03/11/2022 03/11/2022 A 5,000 03/11/2024 03/11/2032 Common Stock 5,000 (3) 5,000 D
Option to purchase common stock(4) $2.2 03/11/2022 03/11/2022 A 5,000 03/11/2025 03/11/2032 Common Stock 5,000 (4) 5,000 D
Explanation of Responses:
1. Represents the grant of non-qualified stock options to purchase 2,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vested and exercisable on the date of grant. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
2. Represents the grant of non-qualified stock options to purchase 3,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2023. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
3. Represents the grant of non-qualified stock options to purchase 5,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2024. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
4. Represents the grant of non-qualified stock options to purchase 5,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2025. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
/s/ Ian K. Patel 03/17/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.